IHH Healthcare Berhad (SGX:Q0F)
| Market Cap | 24.28B +28.7% |
| Revenue (ttm) | 8.28B +5.2% |
| Net Income | 673.24M -12.0% |
| EPS | 0.08 -12.2% |
| Shares Out | n/a |
| PE Ratio | 36.07 |
| Forward PE | 32.63 |
| Dividend | 0.03 (1.20%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 1,900 |
| Open | 2.760 |
| Previous Close | 2.770 |
| Day's Range | 2.710 - 2.760 |
| 52-Week Range | 1.890 - 3.070 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About IHH Healthcare Berhad
IHH Healthcare Berhad, an investment holding company, offers healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Europe, and internationally. It provides primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services. The company also offers secondary care facilities, including medical emergencies and acute treatment, as well as specialist consultation, diagnostics, and lab services; tertiary care services comprising specialist consultative care, advanced treatm... [Read more]
Financial Performance
In 2025, IHH Healthcare Berhad's revenue was 25.75 billion, an increase of 5.59% compared to the previous year's 24.38 billion. Earnings were 2.10 billion, a decrease of -20.93%.
Financial numbers in MYR Financial StatementsNews
IHH Healthcare Berhad Earnings Call Transcript: Q1 2026
Revenue and EBITDA grew 16% year-over-year on a constant currency basis, with strong performances in Malaysia, India, and Turkey. Singapore margins held steady despite headwinds, and transformation initiatives are driving productivity. Double-digit ROE is reaffirmed for 2028.
IHH Healthcare Berhad Slides: Q1 2026
IHH Healthcare Berhad has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 25, 2026.
IHH Healthcare Berhad Quarterly report: Q1 2026
IHH Healthcare Berhad has published its Q1 2026 quarterly earnings report on May 25, 2026.
Why some CEOs are ditching 5-year plans while others are making 10-year bets
Christine Tan speaks with Roger Lee of TAL Apparel, Michael Mertin of AT&S and Dr Prem Kumar Nair of IHH Healthcare about how CEOs are navigating constant disruption, from tariffs and supply chain sho...
How global CEOs are navigating rising costs and supply chain disruption
Christine Tan speaks with Roger Lee of TAL Apparel, Dr Prem Kumar Nair of IHH Healthcare and Michael Mertin of AT&S about how rising energy costs, shipping volatility and supply chain bottlenecks are ...
IHH, DBS sign $194 million loan for safer antibiotic use
IHH Healthcare has signed a S$250 million ($196 million) sustainability-linked loan with Singapore's biggest bank DBS that ties part of the deal to better use of antibiotics at its four Singapore...
Fortis Healthcare surges nearly 3% as IHH commits to raise stake to 50% from 31%
Shares of Fortis Healthcare jumped sharply today, rising 2.13% to ₹825.35 on the NSE after Malaysia’s IHH Healthcare publicly committed to increasing its shareholding in the Indian hospital chain to…
IHH Healthcare Berhad Earnings Call Transcript: Q4 2025
Q4 2025 saw record revenue and EBITDA, with double-digit growth across key markets and strong margin performance. Malaysia and India led growth, while digital transformation and brownfield expansions drive future returns. Dividend payout increased, and outlook for 2026 remains positive.
IHH Healthcare Berhad Quarterly report: Q4 2025
IHH Healthcare Berhad has published its Q4 2025 quarterly earnings report on March 2, 2026.
IHH Healthcare Berhad Slides: Q4 2025
IHH Healthcare Berhad has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 2, 2026.
Fortis Healthcare shares gain today after IHH Healthcare outlines India expansion plan
Friday, February 20: Shares of Fortis Healthcare Limited traded higher after its largest shareholder, IHH Healthcare Berhad, detailed plans to...
IHH Healthcare Berhad Earnings Call Transcript: Q3 2025
Q3 2025 saw double-digit constant currency growth in revenue and EBITDA, with strong performance across Malaysia, India, Turkey, and Europe, and stable margins despite FX and regulatory headwinds. Medical tourism and day care expansion drove growth, while CapEx guidance was revised lower to reflect strategic shifts.
IHH Healthcare Berhad Quarterly report: Q3 2025
IHH Healthcare Berhad has published its Q3 2025 quarterly earnings report on November 27, 2025.
IHH Healthcare Berhad Slides: Q3 2025
IHH Healthcare Berhad has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 27, 2025.
IHH Healthcare Berhad Earnings Call Transcript: Q2 2025
Q2 2025 saw resilient financial results with 7% revenue and 2% EBITDA growth, and even stronger constant-currency gains, driven by increased admissions and a shift to daycare. Margins remained stable amid FX volatility and payer pressure, with robust segment performance and ongoing operational transformation.
IHH Healthcare Berhad Quarterly report: Q2 2025
IHH Healthcare Berhad has published its Q2 2025 quarterly earnings report on August 29, 2025.
IHH Healthcare Berhad Slides: Q2 2025
IHH Healthcare Berhad has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 29, 2025.
How the CEO of one Asia's largest healthcare providers is expanding despite soaring medical inflation
IHH Healthcare is one of Asia's largest healthcare providers, operating a network of hospitals, medical centers, clinics, and ambulatory centers across 10 markets.